A Study of IPL344 in the Treatment of ALS Patients

Clinical trial NCT03652805 · SUSPENDED

Trial details

NCT number: NCT03652805
Sponsor: Immunity Pharma Ltd.
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2018-08-01
Primary completion: 2026-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.